Screener
CG Oncology CGON Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
Based on trailing twelve months.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's return on equity?
- CG Oncology (CGON) reported return on equity of -26.4% in Q2 2026.
- How has CG Oncology's return on equity changed year-over-year?
- CG Oncology's return on equity decreased by 26.0% year-over-year, from -21% to -26.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about CG Oncology's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude